The mangroves are specialized marine environments widely distributed along the coast lines, which support biologically diverse groups of organisms including microbes. The microorganisms present in this ecosystem contr...
详细信息
The mangroves are specialized marine environments widely distributed along the coast lines, which support biologically diverse groups of organisms including microbes. The microorganisms present in this ecosystem contribute significantly in the food web of the tropical marine ecosystem. In the present investigation, Actinomycete isolates obtained from mangrove sediments have been studied for diversity as well as for their bioactive potential. Seven different Actinomycete isolates (MS 1-MS7) were obtained from the sediments collected from the mangrove swamps. The phylogenetic analysis of these isolates showed that out or seven isolates, 3 isolates belong to Streptomyces sp., which has bioactive potential as several bioactive metabolites have been isolated from this group. One bacterium showed genetic similarity with Corynebacterium sp.. The microbes from this group are used for very important industrial applications. Three Actinomycete isolates showed very low similarity with the reported strains from the gene bank. In suggests that, these cultures could be novel and further research work is warranted to prove this speculation. In antagonistic studies, three Actinomycete isolates showed promising results. This investigation highlights the importance of mangrove ecosystem as a rich source of diverse Actinomycete strains for biotechnological applications.
Importance: This post-marketing surveillance study was conducted to evaluate real-world information about the efficacy and safety of oral Tinefcon? tablets (Sphaeranthus indicus based) in plaque psoriasis patients. Ma...
详细信息
Importance: This post-marketing surveillance study was conducted to evaluate real-world information about the efficacy and safety of oral Tinefcon? tablets (Sphaeranthus indicus based) in plaque psoriasis patients. Materials and Methods: Patients aged at least 18 years and older with clinical diagnosis of plaque psoriasis, were enrolled in this open label, non-comparative, multicenter trial. All eligible subjects received four 700 mg Tinefcon? tablets/day for 12 weeks. The primary outcome measure was percent change in Psoriasis Area Severity Index (PASI) score from baseline to week 12. The secondary outcome measures were Physician Global Assessment (PGA), Nail Psoriasis Severity Index (NAPSI), Psoriatic Arthritis Evaluation and Gene Expression Profiling and Immunohistochemistry. Results: After completion of Tinefcon? treatment at 12 weeks, more than half of subjects (52%) achieved PASI 50 response;PASI 75 response was attained in 68 (23%) subjects and PASI 90 response in 22 (7%) subjects. Five subjects with severe psoriasis achieved PASI 90 without receiving any concomitant medication. Reduction in severity as assessed by PGA was observed in more than half of patients with moderate disease. Histopathological evaluation revealed that epidermal thickness was considerably reduced in 66% of subjects. The expression of inflammatory marker S100A9 protein was(meaningfully reduced in 60% patients with non-significant reduction of Keratin 10 protein expression. Gene expression analysis showed increase down regulation of SERPINB4;PI3 and KRT16 genes after a 12-week treatment period in subjects with higher PASI scores. Conclusion: Oral Tinefcon? tablets showed good efficacy and had a favorable safety profile in plaque psoriasis patients.
暂无评论